We are live on ! Find out more
DNA icon

Ginkgo Bioworks
DNA

165 hedge funds and large institutions have $375M invested in Ginkgo Bioworks in 2025 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 46 increasing their positions, 34 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

129% more call options, than puts

Call options by funds: $22.1M | Put options by funds: $9.64M

105% more capital invested

Capital invested by funds: $183M → $375M (+$192M)

67% more funds holding in top 10

Funds holding in top 10: 3 → 5 (+2)

35% more repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 34

3% more first-time investments, than exits

New positions opened: 36 | Existing positions closed: 35

0.76% more ownership

Funds ownership: 71.16% → 71.93% (+0.76%)

0% more funds holding

Funds holding: 165 → 165 (0)

Holders
165
Holders Change
–
Holders Change %
0%
% of All Funds
2.17%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.07%
New
36
Increased
46
Reduced
34
Closed
35
Calls
$22.1M
Puts
$9.64M
Net Calls
+$12.5M
Net Calls Change
+$10.3M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$14M
2
National Bank of Canada
National Bank of Canada
Quebec, Canada
+$3.83M
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$3.71M
4
Goldman Sachs
Goldman Sachs
New York
+$3.53M
5
PGCM
Prescott Group Capital Management
Oklahoma
+$3.18M

Top Sellers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
-$8.34M
2
OM
Opaleye Management
Massachusetts
-$5.38M
3
Two Sigma Advisers
Two Sigma Advisers
New York
-$3.24M
4
CSS
Cubist Systematic Strategies
Connecticut
-$3.2M
5
PP
PDT Partners
New York
-$2.45M
Name Holding Trade Value Shares
Change 		Change in
Stake
PAS
176
Point72 Asia (Singapore)
Singapore
– -$320K -56,078 Closed
HF
177
HRT Financial
New York
– -$290K -51,039 Closed
OAC
178
OMERS Administration Corp
Ontario, Canada
– -$226K -39,700 Closed
Simplex Trading
179
Simplex Trading
Illinois
– -$293K -37,775 Closed
QC
180
Quantessence Capital
New York
– -$174K -30,550 Closed
Acadian Asset Management
181
Acadian Asset Management
Massachusetts
– -$120K -21,263 Closed
BFM
182
Boothbay Fund Management
New York
– -$117K -20,534 Closed
SW
183
SVB Wealth
Massachusetts
– -$99K -17,374 Closed
FRM
184
Fox Run Management
Connecticut
– -$76.4K -13,407 Closed
QCG
185
Quadrant Capital Group
Ohio
– -$71.2K -12,499 Closed
Wolverine Trading
186
Wolverine Trading
Illinois
– -$71.3K -11,654 Closed
CFM
187
Catalyst Funds Management
Australia
– -$57.8K -10,146 Closed
BHCM
188
Brevan Howard Capital Management
Jersey
– -$57.8K -10,145 Closed
KBC Group
189
KBC Group
Belgium
– -$18K -3,113 Closed
PD
190
Point72 (DIFC)
United Arab Emirates
– -$6.62K -1,162 Closed
Comerica Bank
191
Comerica Bank
Texas
– -$1.81K -317 Closed
CCM
192
Coldstream Capital Management
Washington
– -$1.03K -180 Closed
HCP
193
Hexagon Capital Partners
Arkansas
– -$1.01K -178 Closed
ACM
194
Aquatic Capital Management
Illinois
– -$832 -146 Closed
RA
195
Rise Advisors
New York
– -$279 -49 Closed
CA
196
Continuum Advisory
Idaho
– -$114 -20 Closed
QC
197
Quent Capital
New York
– -$74 -13 Closed
4 5 6 7
8

DNA Hedge Fund Activity: Q2 2025 in Review

165 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Ginkgo Bioworks (DNA) for Q2 2025, worth a combined $375M — up 105% from $183M a quarter earlier.

Buyers outnumbered sellers: 36 funds opened new DNA positions and 35 closed out — a net gain of 1 holder — while 46 added to existing stakes and 34 trimmed.

The largest buyer was BlackRock, adding an estimated $14M. The largest seller was EcoR1 Capital, exiting entirely with an estimated $8.34M sold.

  • 165 institutional investors held Ginkgo Bioworks (DNA) as of Q2 2025, unchanged from Q1 2025.
  • Funds reported $375M of Ginkgo Bioworks stock for Q2 2025, up 105% quarter-over-quarter.
  • 36 funds opened new Ginkgo Bioworks positions in Q2 2025 and 35 closed out, a net change of +1 holder.
  • The largest Ginkgo Bioworks buyer in Q2 2025 was BlackRock, an estimated $14M added.
  • The largest Ginkgo Bioworks seller in Q2 2025 was EcoR1 Capital, an estimated $8.34M sold.

Based on aggregated 13F filings for Q2 2025.